Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: Therapeutic implications in human hypertension

Clinical and Experimental Hypertension

Volumn 36, Issue 1, 2014, Pages 17-26

  Rodrigo, Ramón ^a   Miranda Merchak, Andres ^a   Grau, Rodrigo Valenzuela ^a   Bachler, Juan P ^a   Vergara, Leonardo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

(Na,K) ATPase; Essential hypertension; Fatty acid composition; Membrane fluidity; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ADENOSINE TRIPHOSPHATASE; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FATTY ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; PLACEBO; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ERYTHROCYTE; ESSENTIAL HYPERTENSION; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; HYPERTENSION; MALE; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; MIDDLE AGED; OXIDATIVE STRESS; SODIUM-POTASSIUM-EXCHANGING ATPASE; VITAMIN E; VITAMINS;

EID: 84892598472     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.783048     Document Type: Article

References (74)

1. Briones AM, Touyz RM. Oxidative stress and hypertension: Current concepts. Curr Hypertens Rep 2010;12:135-42
2. Cottone S, Lorito MC, Riccobene R, et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008;21:175-9
3. Schulz E, Jansen T, Wenzel P, et al. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008;10:1115-26
4. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008;31:S181-4
5. Sedeek M, Hébert RL, Kennedy CR, et al. Molecular mechanisms of hypertension: Role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 2009;18:122-7
6. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71:247-58
7. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: Implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005;7:1302-14
8. Puddu P, Puddu GM, Cravero E, et al. The molecular sources of reactive oxygen species in hypertension. Blood Press 2008;17:70-7
9. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance? Hypertension 2004;44:248-52
10. Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: Relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 2002;53: 515-24
11. Tsuda K. Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: An electron spin resonance investigation. Int Heart J 2010;51:121-4
12. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 2005;205:1-16
13. Kalous M, Drahota Z. The role of mitochondria in aging. Physiol Res 1996;45:351-9
14. Cazzola R, Rondanelli M, Russo-Volpe S, et al. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 2004;45:1846-51
15. Vajreswari A, Rupalatha M, Rao PS. Effect of altered dietary n-6-To-n-3 fatty acid ratio on erythrocyte lipid composition and membrane-bound enzymes. J Nutr Sci Vitaminol (Tokyo) 2002;48: 365-70
16. Kato M, Hayashi R, Tsuda T, Taniguchi K. High pressure-induced changes of biological membrane. Study on the membrane-bound Na(-)/K(-)-ATPase as a model system. Eur J Biochem 2002;269: 110-18
17. Tsuda K, Nishio I. An association between plasma asymmetric dimethylarginine and membrane fluidity of erythrocytes in hypertensive and normotensive men: An electron paramagnetic resonance investigation. Am J Hypertens 2005;18:1243-8
18. Rodrigo R, Bächler JP, Araya J, et al. Relationship between (Na,K)- ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem 2007;303:73-81
19. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20:392-7
20. Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007;21:111-27
21. Schyvens CG, Andrews MC, Tam R, et al. Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats. Clin Exp Hypertens 2007;29:465-78
22. Rodrigo R, Miranda A. Vitamin C: Nutritional role, supplementation in pathophysiological states & side effects. New York: Nova Publishers; 2010
23. Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and -carotene. Am J Clin Nutr 1995;62: 1322S-6S
24. May JM, Qu ZC, Mendiratta S. Protection and recycling of a-Tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 1998;349:281-9
25. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-Tocopherol (vitamin E). Circ Res 2000;87:349-54
26. Ulker S, McKeown P, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534-9
27. Attia DM, Verhagen AM, Stroes ES, et al. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J. Am. Soc. Nephrol 2001;12:2585-93
28. Abdollahzad H, Eghtesadi S, Nourmohammadi I, et al. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res 2009;79:281-7
29. Myers MG, Tobe SW, McKay DW, Bolli P. New algorithm for the diagnosis of hypertension. Am J Hypertens 2005;8:1369-74
30. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5-10
31. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;289: 2560-72
32. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42
33. O'Brien E, Mee F, Atkins N, O'Malley K. Short report: Accuracy of the Spacelabs 90207 determined by to the British Hypertension Society Protocol. J Hypertens 1991;9:573-4
34. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-Arterial blood pressure. Hypertension 1992;20:227-32
35. Sun M, Tien J, Jones R, Ward R. A new approach to reproducibility assessment: Clinical evaluation of SpaceLabs Medical oscillometric blood pressure monitor. Biomed Instrum Technol 1996;30:439-48
36. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as: A measure of ''antioxidant power'': The FRAP assay. Anal Biochem 1996;239:70-6
37. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74:214-26
38. Milne GL, Musiek ES, Morrow JD. F(2)-isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers 2005;10:10-23
39. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using AchE as label: An alternative to radioimmunoassay. Anal Chem 1985;57:1170-3
40. Chung WY, Chung JK, Szeto YT, et al. Plasma ascorbic acid: Measurement, stability and clinical utility revisited. Clin Biochem 2001;34:623-7
41. Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422-7
42. Katz AI, Epstein FH. The role of sodium-potassium-Activated adenosine triphosphatase in the reabsorption of sodium by the kidney. J Clin Invest 1967;46:1999-2011
43. Taussky HH, Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 1953;202: 675-85
44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75
45. Huertas JR, Palomino N, Ochoa JJ, et al. Lipid peroxidation and antioxidants in erythrocyte membranes of full-Term and preterm newborns. Biofactors 1998;8:133-7
46. Bligh EG, Dyer WJ. A rapid method of total lipid extraction. Can J Biochem Physiol 1959;37: 911-17
47. Holman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 1989; 86:4720-4
48. Rodrigo R, Prat H, Passalacqua W, et al. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond) 2008;114:625-34
49. Begg DP, Sinclair AJ, Stahl LA, et al. Hypertension induced by omega-3 polyunsaturated fatty acid deficiency is alleviated by alpha-linolenic acid regardless of dietary source. Hypertens Res 2010;33:808-13
50. Krug S, Zhang Y, Mori TA, et al. N-Acetylcysteine prevents but does not reverse dexamethasone-induced hypertension. Clin Exp Pharmacol Physiol 2008;35:979-81
51. Herrera EA, Verkerk MM, Derks JB, Giussani DA. Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats. PLoS One 2010;5:e9250
52. Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: A randomized controlled trial. J Hypertens 2009;27:1863-72
53. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr 2009;102:1065-74
54. Begg DP, Sinclair AJ, Stahl LA, et al. Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hypertens 2010;23:125-8. Epublication 5 Nov 2009
55. Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003;41:1096-101
56. Uyuklu M, Meiselman HJ, Baskurt O. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. Clin Hemorheol Microcirc 2007;36:25-33
57. Tsuda K. Associations between high-sensitivity C-reactive protein and membrane fluidity of red blood cells in hypertensive elderly men: An electron spin resonance study. Int J Hypertens 2012;2012: 292803
58. Uydu HA, Yildirmis S, Orem C, et al. The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia. J Membrane Biol 2012;245: 697-705
59. Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 2004;44: 273-82
60. Malfatti CR, Burgos LT, Rieger A, et al. Decreased erythrocyte NA-,K-ATPase activity and increased plasma TBARS in prehypertesive patients. Scientific World Journal 2012;2012: 348246
61. Rodrigo R. Hypertension. In: Rodrigo R, editor. Oxidative stress and antioxidants: Their role in human disease. New York: Nova Publishers; 2009b: Pp. 25-62
62. Sládková M, Kojsová S, Jendeková L, Pechánová O. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats. Physiol Res 2007;56: S85-91
63. Tsuda K, Nishio I, Masuyama Y. The role of sodium-potassium adenosine triphosphatase in the regulation of membrane fluidity of erythrocytes in spontaneously hypertensive rats: An electron paramagnetic resonance investigation. Am J Hypertens 1997;10: 1411-14
64. Kocak-Toker N, Giris M, Tulubas F, et al. Peroxynitrite induced decrease in Na-, K-ATPase activity is restored by taurine. World J Gastroenterol 2005;11:3554-7
65. Rupérez FJ, García-Martínez D, Baena B, et al. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. J Pharm Pharmacol 2008;60: 871-8
66. Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007;21:111-27
67. Herrera E, Jiménez R, Aruoma OI, et al. Aspects of antioxidant foods and supplements in health and disease. Nutr Rev 2009;67: S140-4
68. Evans ZP, Mandavilli BS, Ellett JD, et al. Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc 2009;41: 4094-8
69. Evans ZP, Ellett JD, Fariss MW, et al. Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers. Transplant Proc 2008;40:3327-9
70. Berthiaume JM, Oliveira PJ, Fariss MW, Wallace KB. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol 2005;5: 257-67
71. Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 2005;81: 736-45
72. Roberts 2nd LJ, Traber MG, Frei B. Vitamins E and C in the prevention of cardiovascular disease and cancer in men. Free Radic Biol Med 2009;46:1558
73. Rodrigo R, Prat H, Passalacqua W, et al. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007;30: 1159-67
74. Martina V, Masha A, Gigliardi VR, et al. Long-Term Nacetylcysteine and L-Arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008;31:940-4.